Skip to content
CFEDSC
  • Home
  • About CFEDSC
  • About Cystic Fibrosis
  • Research Posts
    • Research Reports
    • Abstracts
    • Full Length Papers
    • Clinical Trial Reports
  • About Our Team
  • Legal Information
  • Submit a Paper

Feasibility of placebo-controlled trial designs for new CFTR modulator evaluation

March 23, 2023August 28, 2017 by Cystic Fibrosis Educational Services

Feasibility of placebo-controlled trial designs for new CFTR modulator evaluation

Categories Full Length Papers Tags Full Length Papers
Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo
Improving the care of patients with cystic fibrosis (CF)
« Previous Post
Next Post »

Quick Links

  • Research Pipeline
  • Clinical Trials
  • Legal Help & Medical Insurance
  • CF Services Pharmacy

Current News and Events

  • CFTR Modulation Research funded by CFFOctober 4, 2017
  • Interim Data from Clinical Trial Support MS1819 as Potential Therapy for EPI in CF PatientsOctober 2, 2017
  • Enrollment Underway in CF Clinical Trial for Ear Toxicity Caused by AntibioticsOctober 2, 2017
  • ProQR’s Inhaled RNA Therapy Improves CF Symptoms in Phase 1 Clinical TrialOctober 2, 2017
  • CF Patient, Recovering from Double Transplant, Inspires ‘Lunges4Lungs’ FundraiserSeptember 29, 2017
  • Vizient Awards Alcresta Contract for Relizorb, Which Helps CF Patients Digest Healthy FatsSeptember 29, 2017
  • What’s Next for the CF Community and Health Care ReformSeptember 7, 2017
Copyright © 2023 - Cystic Fibrosis Educational Services | Powered By: Thump Local